我们推荐在您的浏览器上开启Javascript，以获得最佳效果。

COL3 抗体

Name: COL3 抗体
Brand: antibodies-online
SKU: ABIN135050
Availability: OutOfStock

COL3 适用: 人 ELISA 宿主: 山羊 Polyclonal unconjugated

Paraffin embedded human gastric cancer tissue was stained with Goat IgG-UNLB isotype control, DAB, and hematoxylin. (COL3 抗体)

IHC

1 image

(29 references)

产品编号 ABIN135050

发货至: 中国

Datasheet as PDF

抗原 See all COL3 抗体

COL3 (Collagen, Type III (COL3))
适用
45

27

25

15

15

6

4

1
人
宿主
35

8

7
山羊
Compatible Secondaries
克隆类型
41

9
多克隆
标记
27

6

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1
This COL3 antibody is un-conjugated
应用范围
38

28

22

13

13

13

11

9

9

6

3

2

1
ELISA

特异性

Reacts with conformational determinants on type III collagen Referenced species reactivities include - Human 2,5,11,12,32,33,35-37 Chicken 22,23 Hamster 18,24 Mouse 4,6,13,15,34,39 Chinchilla 26 Porcine 1,5,17,29 Rat 5,10,14,20,31 Equine 25 Rabbit 9,16,19,21,38 Bovine 8,27 Feline 30 Rhesus 7 Canine 3,5 Guinea Pig 21 Tree Shrew 28

交叉反应（详细）

Exhibits < 10 % cross reactivity with collagen type II, III, IV, V and VI. The antibody has not been tested for reactivity with other ECM proteins (e.g., laminin, fibronectin).

产品特性

Goat Anti-Type III Collagen-UNLB

纯化方法

Purification Method: Affinity chromatography on type III collagen covalently linked to agarose.

亚型

IgG

Top Product

Discover our top product COL3 Primary Antibody
anti-Collagen, Type III (COL3) antibody
COL3 适用: 人, Cow, 哺乳动物 WB, ELISA, IHC, IP 宿主: 兔 Polyclonal unconjugated

anti-Collagen, Type III (COL3) (AA 1301-1400) antibody
COL3 适用: 人, 大鼠, 小鼠, 犬, 兔 WB, ELISA, IHC (fro), IHC (p), IF (cc), IF (p) 宿主: 兔 Polyclonal unconjugated

anti-Collagen, Type III (COL3) antibody
COL3 适用: 人 WB, IF, IP 宿主: 兔 Monoclonal unconjugated

anti-Collagen, Type III (COL3) antibody (Biotin)
COL3 适用: 人 ELISA 宿主: 山羊 Polyclonal Biotin

anti-Collagen, Type III (COL3) antibody (HRP)
COL3 适用: 人, Cow, 哺乳动物 WB, ELISA, IHC, IP 宿主: 兔 Polyclonal HRP

anti-Collagen, Type III (COL3) antibody
COL3 适用: 人, 大鼠, 小鼠 WB 宿主: 小鼠 Monoclonal unconjugated

anti-Collagen, Type III (COL3) antibody (Magnetic Particles)
COL3 适用: 人, 大鼠, 小鼠 IP 宿主: 小鼠 Monoclonal Col-29 Magnetic Particles

anti-Collagen, Type III (COL3) antibody (Biotin)
COL3 适用: 人, Cow, 哺乳动物 WB, ELISA, IHC, IP 宿主: 兔 Polyclonal Biotin

anti-Collagen, Type III (COL3) antibody (FITC)
COL3 适用: 人, Cow, 哺乳动物 WB, ELISA, IHC, IP 宿主: 兔 Polyclonal FITC

anti-Collagen, Type III (COL3) (AA 81-130) antibody
COL3 适用: 人, 大鼠, 小鼠 ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated

应用备注
- Applications: Quality tested applications include - ELISA ,
- Other referenced applications include - IHC-PS , IHC-FS , ICC , EM , FC , WB
- Working Dilutions: ELISA BIOT conjugate 1:1,000 - 1:4,000
样本量

0,5 mL

限制

仅限研究用
浓度

0.4 mg/mL

缓冲液

0.2 mg of purified immunoglobulin in 0.5 mL of borate buffered saline,  pH 8.2. No preservatives or amine-containing buffer salts added

储存液

Without preservative

注意事项

Each reagent is stable for the period shown on the bottle label if stored as directed.

储存条件

4 °C

储存方法

Store at 2-8°C
Fernandes, Reilly, Schrock, Hocking, Oakes, Fowell: "CD4+ T Cell Interstitial Migration Controlled by Fibronectin in the Inflamed Skin." in: Frontiers in immunology, Vol. 11, pp. 1501, (2020) (PubMed).

Sembach, Fink, Johansen, Boland, Secher, Thrane, Nielsen, Fosgerau, Vrang, Jelsing, Pedersen, Østergaard: "Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice." in: Physiological reports, Vol. 7, Issue 24, pp. e14333, (2020) (PubMed).

Becker, OConnell, Vo, Cain, Tampe, Bizarro, Sugimoto, McGow, Asara, Lovisa, McAndrews, Zielinski, Lorenzi, Zeisberg, Raza, LeBleu, Kalluri: "Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer." in: Cell reports, Vol. 31, Issue 9, pp. 107701, (2020) (PubMed).

Buhl, Djudjaj, Klinkhammer, Ermert, Puelles, Lindenmeyer, Cohen, He, Borkham-Kamphorst, Weiskirchen, Denecke, Trairatphisan, Saez-Rodriguez, Huber, Olson, Floege, Boor: "Dysregulated mesenchymal PDGFR-β drives kidney fibrosis." in: EMBO molecular medicine, Vol. 12, Issue 3, pp. e11021, (2020) (PubMed).

Dobie, Wilson-Kanamori, Henderson, Smith, Matchett, Portman, Wallenborg, Picelli, Zagorska, Pendem, Hudson, Wu, Budas, Breckenridge, Harrison, Mole, Wigmore, Ramachandran, Ponting, Teichmann, Marioni et al.: "Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis. ..." in: Cell reports, Vol. 29, Issue 7, pp. 1832-1847.e8, (2020) (PubMed).

Welc, Flores, Wehling-Henricks, Ramos, Wang, Bertoni, Tidball: "Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy." in: Nature communications, Vol. 10, Issue 1, pp. 2788, (2019) (PubMed).

Delestre-Delacour, Carmon, Laguerre, Estay-Ahumada, Courel, Elias, Jeandel, Rayo, Peinado, Sengmanivong, Gasman, Coudrier, Anouar, Montero-Hadjadje: "Myosin 1b and F-actin are involved in the control of secretory granule biogenesis." in: Scientific reports, Vol. 7, Issue 1, pp. 5172, (2019) (PubMed).

He, Zhang, Tolosa, Goru, Chen, Misra, Robinson, Yuen: "A new, easily generated mouse model of diabetic kidney fibrosis." in: Scientific reports, Vol. 9, Issue 1, pp. 12549, (2019) (PubMed).

Ellenbroek, de Haan, van Klarenbosch, Brans, van de Weg, Smeets, de Jong, Arslan, Timmers, Goumans, Hoefer, Doevendans, Pasterkamp, Meyaard, de Jager: "Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice." in: Scientific reports, Vol. 7, Issue 1, pp. 18039, (2019) (PubMed).

Qiao, Dai, Nikolova, Jin, Li, Xiao, Li, Moy, Xiao: "Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin." in: Molecular therapy. Methods & clinical development, Vol. 9, pp. 47-56, (2018) (PubMed).

Wada, Kawada, Hirai, Toda, Iwamoto, Hasegawa, Sakai: "Enhanced anastomotic healing by Daikenchuto (TJ-100) in rats." in: Scientific reports, Vol. 8, Issue 1, pp. 1091, (2018) (PubMed).

Westendorp, Büller, Karpus, van Dop, Koster, Versteeg, Koelink, Snel, Meisner, Roelofs, Uhmann, Ver Loren van Themaat, Heijmans, Hahn, Muncan, Wildenberg, van den Brink: "Indian Hedgehog Suppresses a Stromal Cell-Driven Intestinal Immune Response." in: Cellular and molecular gastroenterology and hepatology, Vol. 5, Issue 1, pp. 67-82.e1, (2018) (PubMed).

de Bruyn, Becker, Steenkamer, Wildenberg, Meijer, Buskens, Bemelman, Löwenberg, Ponsioen, van den Brink, DHaens: "Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease." in: PLoS ONE, Vol. 13, Issue 1, pp. e0190999, (2018) (PubMed).

Pu, Zhang, Huang, Tian, He, Wang, Zhang, Liu, Li, Li, Zhao, Liu, Lu, Zhou, Huang, Nie, Yan, Hui, Lui, Zhou: "Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration." in: Nature communications, Vol. 7, pp. 13369, (2018) (PubMed).

Poosti, Bansal, Yazdani, Prakash, Beljaars, van den Born, de Borst, van Goor, Hillebrands, Poelstra: "Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice." in: Oncotarget, Vol. 7, Issue 34, pp. 54240-54252, (2018) (PubMed).

Hijmans, Shrestha, Sarpong, Yazdani, El Masri, de Jong, Navis, Vivès, van den Born: "High sodium diet converts renal proteoglycans into pro-inflammatory mediators in rats." in: PLoS ONE, Vol. 12, Issue 6, pp. e0178940, (2017) (PubMed).

Hijmans, Rasmussen, Yazdani, Navis, van Goor, Karsdal, Genovese, van den Born: "Urinary collagen degradation products as early markers of progressive renal fibrosis." in: Journal of translational medicine, Vol. 15, Issue 1, pp. 63, (2017) (PubMed).

Poosti, Pham, Oosterhuis, Poelstra, van Goor, Olinga, Hillebrands: "Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo." in: Disease models & mechanisms, Vol. 8, Issue 10, pp. 1227-36, (2016) (PubMed).

Yazdani, Hijmans, Poosti, Dam, Navis, van Goor, van den Born: "Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats." in: Disease models & mechanisms, Vol. 8, Issue 8, pp. 919-30, (2016) (PubMed).

Abdul, Dixon, Walker, Horabin, Smith, Weir, Brewster, Deehan, Mann, Borthwick: "Fibrosis is a common outcome following total knee arthroplasty." in: Scientific reports, Vol. 5, pp. 16469, (2016) (PubMed).

show more references
抗原

COL3 (Collagen, Type III (COL3))

别名

Type III Collagen (COL3 产品)

别名

PT antibody, RPRGL2 antibody, THPH1 antibody, Cf-2 antibody, Cf2 antibody, FII antibody, thrombin antibody, prothrombin antibody, coagulation factor II, thrombin antibody, coagulation factor II antibody, F2 antibody